Technology Week Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.

Press releases published on April 20, 2026

Apr. 20, 2026

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire

Apr. 20, 2026

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

Indeterminate GlobeNewswire

Apr. 20, 2026

Aptean introduces AI platform and AI agents for Business Central On-Premises Customers

Indeterminate GlobeNewswire

Apr. 20, 2026

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

Indeterminate GlobeNewswire

Apr. 20, 2026

AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease

Indeterminate GlobeNewswire

Apr. 20, 2026

Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment

Indeterminate GlobeNewswire

Apr. 20, 2026

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Indeterminate GlobeNewswire

Apr. 20, 2026

RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue

Indeterminate GlobeNewswire

Apr. 20, 2026

Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

Indeterminate GlobeNewswire

Apr. 20, 2026

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

Indeterminate GlobeNewswire

Apr. 20, 2026

SLEEK Debuts Universal Profiles at Sophie Passmann Book Club, Pioneering a New Template for Cultural Fan Activation

Indeterminate GlobeNewswire

Apr. 20, 2026

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System

Indeterminate GlobeNewswire

Apr. 20, 2026

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Xtract One Selected by Health PEI for Phased Rollout of Tech-Driven Security Systems Across Prince Edward Island

Indeterminate GlobeNewswire

Apr. 20, 2026

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Indeterminate GlobeNewswire